Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.1K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.1K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.0K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.0K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

355
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
355
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

323
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
323
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

325
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
325

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Effectiveness of digital therapy added to the usual intervention for smoking cessation in primary care].

Semergen·2026
Same journal

[From training to competency: The family physician facing artificial intelligence].

Semergen·2026
Same journal

[New perspectives in the management of dyslipidemia and the role of PCSK9 inhibitors].

Semergen·2026
Same journal

[Adult ADHD: Underdiagnosis, healthcare barriers, and the role of primary care].

Semergen·2026
Same journal

Mepifilina in Spain: Accessible evidence, guideline positioning, utilization and proportionate reassessment.

Semergen·2026
Same journal

Trends and disparities in influenza and pneumonia associated sepsis mortality among older adults in the United States, 1999-2022: A retrospective population-based study.

Semergen·2026

Related Experiment Video

Updated: Apr 1, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

704

[Antidepressants in the elderly].

M C Cortajarena García1, S Ron Martin1, E Miranda Vicario1

  • 1Centro de Salud Mental Aiala-Llodio (Alava), Red de Salud Mental Araba, Osakidetza, España.

Semergen
|October 3, 2015
PubMed
Summary

Elderly depression requires tailored antidepressant strategies due to increased relapses and complex treatment factors. Understanding drug effectiveness, safety, and tolerance is crucial for successful primary care management.

Keywords:
AncianoAntidepresivosAntidepressantsDepresiónDepressionElderly

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.7K
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

978

Related Experiment Videos

Last Updated: Apr 1, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

704
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.7K
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

978

Area of Science:

  • Geriatric Medicine
  • Psychiatry
  • Pharmacology

Background:

  • Depression in the elderly is a prevalent and complex disorder.
  • Older adults experience higher relapse rates and require prolonged treatment.
  • Pharmacological treatment presents challenges due to concurrent health factors.

Purpose of the Study:

  • To emphasize the importance of a foundational antidepressant regimen for effective elderly depression management in primary care.
  • To highlight the necessity of understanding antidepressant characteristics for optimal patient selection.

Main Methods:

  • Review of pharmacological approaches for geriatric depression.
  • Analysis of factors influencing antidepressant selection in the elderly.
  • Emphasis on evidence-based treatment guidelines.

Main Results:

  • A basic antidepressant scheme is vital for efficient and successful treatment from primary care.
  • All antidepressants possess side effects that necessitate careful consideration.
  • Selection criteria must prioritize effectiveness, safety, and patient tolerance.

Conclusions:

  • Effective management of depression in the elderly necessitates a well-defined antidepressant strategy.
  • Primary care physicians must be knowledgeable about drug profiles to ensure optimal patient outcomes.
  • Balancing efficacy, safety, and tolerability is key to successful geriatric depression pharmacotherapy.